SCHEMBL2391613

SCHEMBL2391613

O=C(O)Cc1ccccc1-c1ccc(Br)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.53
FFAR4 Q5NUL3 1/20 0.53
AKR1B1 P15121 1/20 0.50
PTGS1 P23219 3/20 0.48
PTGS2 P35354 2/20 0.48
LMNA P02545 2/20 0.48
ABCB11 O95342 1/20 0.48
ADORA1 P30542 1/20 0.48
KMT2A Q03164 2/20 0.47
PTGER1 P34995 2/20 0.47
PTGER4 P35408 2/20 0.47
PTGER3 P43115 2/20 0.47
PTGER2 P43116 2/20 0.47
SLC6A3 Q01959 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
HTT P42858 2/20 0.44
ABCC4 O15439 1/20 0.44
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
PTGDR2 Q9Y5Y4 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2432355 0.87 FFAR1 (0.48) FFAR1FFAR4LMNAKMT2APTGER1
SCHEMBL5961842 0.87 PTGS1 (0.59) AKR1B1PTGS1PTGS2LMNAKMT2A
SCHEMBL538512 0.87 KMT2A (0.60) FFAR1FFAR4AKR1B1PTGS1PTGS2
SCHEMBL27701716 0.85 KMT2A (0.58) FFAR1FFAR4AKR1B1PTGS1PTGS2
Hydrochloric Acid SCHEMBL11895689 0.85 KMT2A (0.58) FFAR1FFAR4AKR1B1PTGS1PTGS2
Ammonia Solution, Strong SCHEMBL27926479 0.85 KMT2A (0.58) FFAR1FFAR4AKR1B1PTGS1PTGS2
SCHEMBL28594606 0.85 KMT2A (0.58) FFAR1FFAR4AKR1B1PTGS1PTGS2
SCHEMBL29512995 0.85 KMT2A (0.58) FFAR1FFAR4AKR1B1PTGS1PTGS2
SCHEMBL8645744 0.85 PTGS1 (0.55) AKR1B1PTGS1PTGS2LMNAKMT2A
SCHEMBL2391344 0.84 FFAR1 (0.46) FFAR1FFAR4LMNAKMT2ASLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-06-07 US disclosed
CN-102282124-A Biphenylacetamide derivative 2011-12-14 CN disclosed
EP-2374790-A1 BIPHENYLACETAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2011-10-12 EP disclosed
EP-2374790-A1 BIPHENYLACETAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2011-10-12 EP disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142771-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 FFAR1 223/4885FFAR4 621/4885AKR1B1 734/4885
US-20110224304-A1 BIPHENYLACETAMIDE DERIVATIVE HRH3, KCNH3, BRPF3 FFAR1 223/4885FFAR4 621/4885AKR1B1 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.